Effect of diagnostic testing on medicines used by febrile children less than five years in 12 malaria-endemic African countries: a mixed-methods study.

• In 2010, WHO revised guidelines to recommend testing all suspected malaria cases prior to treatment. Yet, evidence to assess programmes is largely derived from limited facility settings in a limited number of countries. National surveys from 12 sub-Saharan African countries were used to examine the effect of diagnostic testing on medicines used by febrile children under five years at the population level, including stratification by malaria risk, transmission season, source of care, symptoms, and age.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Hälsovetenskap (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Health Sciences (hsv//eng)

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Infektionsmedicin (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Infectious Medicine (hsv//eng)

Keyword

Africa South of the Sahara

epidemiology

Anti-Bacterial Agents

therapeutic use

Antimalarials

therapeutic use

Artemisinins

therapeutic use

Child

Preschool

Diagnostic Tests

Routine

Drug Combinations

Female

Fever

diagnosis

drug therapy

epidemiology

Humans

Infant

Infant

Newborn

Logistic Models

Malaria

diagnosis

drug therapy

epidemiology

Male

Risk

Seasons

Socioeconomic Factors

Publication and Content Type

ref (subject category)

art (subject category)